Nova Eye Medical Limited
EYE
Rank in Stocks
#25061
Nova Eye Medical Limited specializes in the creation, advancement,... Nova Eye Medical Limited specializes in the creation, advancement, distribution, marketing, sale, and servicing of surgical equipment dedicated to treating glaucoma. Its diverse product line features iTrack, a surgical system engineered to decrease intraocular pressure (IOP) in adult patients with open-angle glaucoma, and iTrack Advance, an innovative system promoting natural ocular fluid drainage. Furthermore, the company provides Molteno3, a glaucoma drainage device for individuals suffering from severe or intricate forms of the condition, alongside 2RT, a proprietary laser technology employed to address early to intermediate stages of age-related macular degeneration. With a presence spanning Australia, the United States, Europe, the Asia Pacific, and other international markets, the company, originally established in 1985 as Ellex Medical Lasers Limited, officially became Nova Eye Medical Limited in July 2020. Its corporate headquarters are situated in Kent Town, Australia.
Share Price
$0.10036755
Last synced: 2026-11-10
Market Cap
$28.60M
Change (1 day)
0.00%
Change (1 year)
18.31%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Nova Eye Medical Limited (EYE)
Category
Healthcare
EPS for Nova Eye Medical Limited (EYE)
EPS as of June 2026 TTM: $-0.01
According to Nova Eye Medical Limited's latest financial reports, its current EPS (TTM) is $-0.01. At the end of 2025 the company had an EPS of $-0.02, an increase over its 2024 EPS of $-0.03.
EPS history for Nova Eye Medical Limited from 2000 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-0.01 | -46.50% |
| 2025 | $-0.02 | -16.32% |
| 2024 | $-0.03 | -54.72% |
| 2023 | $-0.06 | 82.76% |
| 2022 | $-0.03 | 57.47% |
| 2021 | $-0.02 | -32.42% |
| 2020 | $-0.03 | 3.15% |
| 2019 | $-0.03 | 13.21% |
| 2018 | $-0.03 | 374.58% |
| 2017 | $-0.01 | -128.64% |
| 2016 | $0.02 | 71.67% |
| 2015 | $0.01 | 73.91% |
| 2014 | $0.01 | -175.82% |
| 2013 | $-0.01 | -181.25% |
| 2012 | $0.01 | -224.44% |
| 2011 | $-0.01 | -123.62% |
| 2010 | $0.04 | -115.70% |
| 2009 | $-0.24 | -495.28% |
| 2008 | $0.06 | 14.55% |
| 2007 | $0.05 | 29.78% |
| 2006 | $0.04 | -427.78% |
| 2005 | $-0.01 | 472.73% |
| 2004 | 0.00 | -113.17% |
| 2003 | $0.02 | -1,213.33% |
| 2002 | 0.00 | -96.30% |
| 2001 | $-0.04 | -51.67% |
| 2000 | $-0.08 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $2.70 | -25,333.64% |
US
|
|
| $4.09 | -38,324.30% |
IE
|
|
| $9.45 | -88,417.76% |
US
|
|
| $2.37 | -22,249.53% |
US
|
|
| $1.77 | -16,642.06% |
US
|
Questions about Nova Eye Medical Limited's earnings per share (EPS)
What is Nova Eye Medical Limited's earnings per share (EPS)?
Nova Eye Medical Limited's earnings per share (EPS) over the last twelve months is $-0.01, as of Jun 2026.
What was Nova Eye Medical Limited's earnings per share (EPS) in 2025?
In 2025, Nova Eye Medical Limited's earnings per share (EPS) was $-0.02, compared with $-0.03 in 2024.
How has Nova Eye Medical Limited's earnings per share (EPS) changed since 2020?
From 2020 to 2025, Nova Eye Medical Limited's earnings per share (EPS) was highest in 2025 ($-0.02) and lowest in 2023 ($-0.06).
How does Nova Eye Medical Limited's earnings per share (EPS) compare with similar companies?
Nova Eye Medical Limited's earnings per share (EPS) ($-0.01) is lower than that of all 5 similar companies listed above. The highest among them is Stryker Corporation, with $9.45.